Survodutide and Tesamorelin Interaction

Monitor
Mechanism-based 55% confidence

Survodutide and Tesamorelin have an interaction requiring monitoring for interaction with 55% confidence. Both Survodutide and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

Survodutide

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Dual agonism: GLP-1R reduces appetite and slows gastric emptying; GCGR increases energy expenditure and hepatic fat oxidation. EC50 0.

Half-life: Approximately 6 days (109-115 hours) Typical dose: 0.6mg starting, titrate up to 3.6-6.0mg weekly weight loss, metabolic
glp1 receptor cardiotoxicinsulin disrupting
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low
Pituitary
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Survodutide, Tesamorelin). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take Survodutide with Tesamorelin?

Yes, but with caution. Both Survodutide and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is Survodutide and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between Survodutide and Tesamorelin?

Both Survodutide and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time Survodutide and Tesamorelin?

Survodutide has a half-life of Approximately 6 days (109-115 hours) and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Survodutide vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.